Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

NCT04147208 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic HBV Infection

Interventions

DRUG: GLS4
DRUG: RTV
DRUG: ETV

Sponsor

Sunshine Lake Pharma Co., Ltd.